741 - 750 of 5662 Results
Title
Year
- Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities2023OPENTitle: Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority CommunitiesJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 37Issue #: 2Start Page: 107End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000556Citation Count: 1
- Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients2023OPENTitle: Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease PatientsJournal Name: Brain SciencesPublisher: MDPI AGVol: 13Issue #: 4Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci13040599Best OA location URL: https://www.mdpi.com/2076-3425/13/4/599/pdf?version=1680501261Citation Count: 6
- Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force2023OPENTitle: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceJournal Name: Value in HealthPublisher: Elsevier BVVol: 26Issue #: 4Start Page: 449End Page: 460Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006Best OA location URL: http://www.valueinhealthjournal.com/article/S1098301522047805/pdfCitation Count: 12
- Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting2023OPENTitle: Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule countingJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-32480-0Best OA location URL: https://www.nature.com/articles/s41598-023-32480-0.pdfCitation Count: 6
-
OPENTitle: Sex differences in associations between APOE ε2 and longitudinal cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 10Start Page: 4651End Page: 4661Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13036Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13036Citation Count: 4
- Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challenge2023OPENTitle: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challengeJournal Name: PLOS Digital HealthPublisher: Public Library of Science (PLoS)Vol: 2Issue #: 3Start Page: e0000208End Page: e0000208Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pdig.0000208Best OA location URL: https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000208&type=printableCitation Count: 0
-
OPENTitle: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assayJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 5Start Page: 696End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51753Citation Count: 13
- Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation2023OPENTitle: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenationJournal Name: Aging CellPublisher: WileyVol: 22Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13814Best OA location URL: https://discovery.dundee.ac.uk/files/99818671/Aging_Cell_2023_Arr_zola_Necroptosis_inhibition_counteracts_neurodegeneration_memory_decline_and_key_hallmarks_of.pdfCitation Count: 9
- Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis2023OPENTitle: Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00491-3Best OA location URL: https://www.nature.com/articles/s41531-023-00491-3.pdfCitation Count: 15
- Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro12023OPENTitle: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103085End Page: 103085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2023.103085Best OA location URL: https://doi.org/10.1016/j.scr.2023.103085Citation Count: 1